September 2012 FDA Recall Drug by Dr. Reddy's Laboratories, Inc.
D-059-2013 - Failed USP Dissolution Test Requirements

This Class II drug recall was voluntarily initiated by Dr. Reddy's Laboratories, Inc. on September 27, 2012 for the product Drug. The FDA reported the reason for recall as failed usp dissolution test requirements. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-059-2013

Reason for Recall
Failed USP Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg.
Initiated
09-27-2012
Reported
11-28-2012
Quantity
1512 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Dr. Reddy's Laboratories, Inc.
Nationwide. No foreign consignees.
Dr. Reddy's Quetiapine Fumarate Tablets, 25mg, Rx Only, 500 tablets. Mfd By: Dr. Reddy's Laboratories Limited, Bachepalli - 502 325, India NDC 55111-249-05

Batch or Lot Expiration Information

Lot# Lot C203090 Exp.03/14